Axsome Therapeutics, Inc. 8-K Filing Report: Key Insights and Future Events
From the provided XML financial report excerpt, the key information can be distilled as follows:
- Entity Information:
- Company Name: Axsome Therapeutics, Inc.
- CIK (Central Index Key): 0001579428
- SEC File Number: 001-37635
- EIN (Employer Identification Number): 45-4241907
- Address: One World Trade Center, 22nd Floor, New York, NY 10007
- Contact Number: (212) 332-3241
- Filing Information:
- Filing Type: 8-K (Current Report)
- Filing Date: February 18, 2025
- Stock Information:
- Common Stock: Par Value of $0.0001 per share
- Ticker Symbol: AXSM
- Exchange: NASDAQ
- Context:
- The report relates to a specific event or information that necessitated the filing of an 8-K, which is typically used to report major events that shareholders should know about.
Insights:
- The filing date indicates that this is a future filing, suggesting that the data relates to an anticipated event or disclosure.
- As an 8-K filing, it may contain significant updates regarding the company’s operations, financial condition, or other major events that could affect stock performance or investor decisions.
- The identification of the company on NASDAQ with a low par value stock may indicate a growth-oriented biotech company, typical in the sector where shares are often issued at low values to raise capital for research and development.
This information can be used by investors and analysts to gauge the company's activities and potential impact on its market performance.